Regulators Grapple With an Unorthodox Therapy

The rapid rise of fecal transplantation, coupled with pressure from enthusiastic patients and doctors, has regulators wondering how to respond. While European and Australian regulators have not yet stepped in, the U.S. Food and Drug Administration asserted its authority over the procedure in May—although it partially backtracked in July.

Read the Full Text. (Login may be required.)

Posted in Health, Biology, Biology